Increased blood-brain barrier permeability in LP-BM5 infected mice is mediated by neuroexcitatory mechanisms

Brain Research

Volumn 839, Issue 1, 1999, Pages 153-163

  Kustova, Yelena ^a   Grinberg, Alexander ^b   Basile, Anthony S ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Blood brain barrier; IgG; Immunodeficiency; LP BM5; MK 801; Mouse; Serum protein

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; DIZOCILPINE; GLUTAMIC ACID; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLASMA PROTEIN; TRANSFERRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; INFECTION; MALE; MOUSE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS;

ANIMALS; BLOOD PROTEINS; BLOOD-BRAIN BARRIER; BRAIN DISEASES; COLORING AGENTS; DIZOCILPINE MALEATE; EVANS BLUE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; PROSENCEPHALON; RECEPTORS, N-METHYL-D-ASPARTATE; RETROVIRIDAE INFECTIONS;

EID: 0033592113     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01734-5     Document Type: Article

References (52)

1. Al-Kassab S., Olsen T.S., Skriver E.B. Blood-brain barrier integrity in patients with cerebral infarction investigated by computed tomography and serum-CSF-albumin. Acta Neurol. Scand. 64:1981;438-445.
2. Annunziata P., Cioni C., Toneatto S., Paccagnini E. HIV-1 gp-120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS. 12:1998;2377-2385.
3. Boado R.J., Pardridge W.M. The brain type glucose transporter mRNA is specifically expressed at the blood-brain barrier. Biochem. Biophys. Res. Commun. 166:1990;174-179.
4. Boertje S.B., Ward S., Robinson A. H2-receptors mediate histamine-induced variations in the permeability of the blood-brain barrier of rats. Res. Commun. Chem. Pathol. Pharmacol. 76:1992;143-154.
5. Bolton C., Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J. Pharm. Exp. Ther. 282:1997;397-402.
6. Broadwell R.D., Sofroniew M.V. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol. 120:1993;245-263.
7. Brosnan C.F., Claudio L., Martiney J.A. The blood-brain barrier during immune responses. Sem. Neurosci. 4:1992;1930-2000.
8. Cavazzuti M., Porro C.A., Biral G.P., Benassi C., Barbieri G.S. Ketamine effects on local cerebral blood flow and metabolism in the rat. J. Cereb. Blood Flow Metab. 7:1987;806-811.
9. Cserr H.F., Harling-Berg C.J., Knopf P.M. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. 2:1992;269-276.
10. DeVries H.E., Blom-Roosenmale M.C.M., van Oosten M., de Boer A.G., van Berkel T.J.C., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:1996;37-43.
11. English J.A., Hemphill K.M., Paul I.A. LP-BM5 infection impairs acquisition, but not performance, of active avoidance responding in C57B1/6 mice. FASEB J. 12:1998;175-179.
12. Espey M.G., Basile A.S. Glutamatergic hyperactivation of the hypothalamic-pituitary-adrenal axis in LP-BM5 infected mice augments immunodeficiency. J. Immunol. 162:1999;4998-5002.
13. M.G. Espey, Y. Kustova, Y. Sei, A.S. Basile, The LP-BM5 murine leukemia virus: impact on the immune and central nervous systems, in: P.K.Y. Wong, W. Lynn (Eds.), Neuroimmunodegeneration, Springer-Verlag, Berlin, 1998, pp. 95-114.
14. Espey M.G., Kustova Y., Sei Y., Basile A.S. Extracellular glutamate levels are elevated in the brains of LP-BM5 infected mice: relevance to retrovirus associated encephalopathies. J. Neurochem. 71:1998;2079-2087.
15. Fiala M., Looney D.J., Stins M., Way D.D., Zhang L., Gan X., Chiappelli F., Schweitzer E.S., Shapshank P., Weinand M., Graves M.C., Witte M., Kim K.S. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3:1997;553-564.
16. Fishman P.S., Farrand D.A., Kristt D.A. Internalization of plasma proteins by cerebellar Purkinje-cells. J. Neurol. Sci. 100:1990;43-49.
17. Krizbai I.A., Deli M.A., Pestenacz A., Siklos L., Szabo C.A., Andras I., Joo F. Expression of glutamate receptors on cultured cerebral endothelial cells. J. Neurosci. Res. 54:1998;814-819.
18. Kustova Y., Espey M.G., Sei Y., Basile A.S. Regional decreases in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus. NeuroReport. 8:1997;1243-1247.
19. Kustova Y., Ha J.-H., Espey M., Sei Y., Basile A.S. The pattern of neurotransmitter alterations in LP-BM5 infected mice are consistent with glutamatergic hyperactivation. Brain Res. 793:1998;119-126.
20. Kustova Y., Sei Y., Goping G., Basile A.S. Gliosis in the LP-BM5 murine leukemia virus-infected mouse: an animal model of retrovirus-induced dementia. Brain Res. 742:1997;271-282.
21. Kustova Y., Sung E.-G., Morse D., Sei Y., Basile A.S. Histological evidence of neuronal degeneration in mice infected with the LP-BM5 murine leukemia virus. Mol. Chem. Neuropath. 35:1998;39-59.
22. Lenhardt T.M., Wiley C.A. Absence of humorally mediated damage within the central nervous system of AIDS patients. Neurology. 39:1989;278-280.
23. Li Y., Kustova Y., Sei Y., Basile A.S. Regional changes in constitutive, but not inducible NOS expression in the brains of mice infected with the LP-BM5 leukemia virus. Brain Res. 752:1997;107-116.
24. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. New Engl. J. Med. 332:1995;934-940.
25. Matute C., Gutierrez-Igarza K., Rio C., Miledi R. Glutamate receptors in astrocytic end-feet. NeuroReport. 5:1994;1205-1208.
26. Mayhan W.G., Didion S.P. Glutamate-induced disruption of the blood-brain barrier in rats: role of nitric oxide. Stroke. 27:1996;965-970.
27. Mihaly A., Bozoky B. Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions. Acta Neuropathol. (Berl.). 65:1984;25-34.
28. Morley P., Small D.L., Murray C.L., Mealing G.A., Poulter M.O., Durkin J.P., Stanimirovic D.B. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 18:1998;396-406.
29. Moses A.V., Nelson J.A. HIV infection of human brain capillary endothelial cells - implications for AIDS dementia. Adv. Neuroimmunol. 4:1994;239-247.
30. Nag S. Vascular changes in the spinal cord in N-methyl-D-aspartate-induced excitotoxicity: morphological and permeability studies. Acta Neuropathol. 84:1992;471-477.
31. G. Nagashima, T.S. Nowak, F. Joo, J. Ikeda, C. Ruetzler, J. Lohr, I. Klatzo, The role of the blood-brain barrier in ischemic brain lesions, in: B.B. Johansson, C. Owman, H. Widner (Eds.), Pathophysiology of the Blood-brain Barrier, Elsevier, Amsterdam, 1990, 311-321.
32. Nishida K., Markey S.P., Skolnick P., Basile A.S., Sei Y. Increases in brain platelet activating factor were inhibited by the N-methyl-D-aspartate antagonist MK-801 in mice infected with the LP-BM5 murine leukemia virus. J. Neurochem. 66:1996;433-435.
33. Oehmichen M., Gencic M. Postmortem diffusion of plasma albumin in rat brain. Z. Rechtsmed. 84:1980;113-123.
34. Pardridge W.M. Advances in cell biology of blood-brain barrier transport. Semin. Cell Biol. 2:1991;419-426.
35. Persidsky Y., Stins M., Way D., Witte M.H., Weinand M., Kim K.S., Bock P., Gendelman H.E., Fiala M. Model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158:1997;3499-3510.
36. Petito C.K., Cash K.S. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome; immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32:1992;658-666.
37. - in the macrophage induced glutamate-dependent cytotoxicity to neurons. J. Immunol. 152:1994;3578-3585.
38. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34:1993;339-350.
39. Sei Y., Arora P.K., Skolnick P., Paul I.A. Spatial learning impairment in a murine model of AIDS. FASEB J. 6:1992;30008-30013.
40. Sei Y., Paul I.A., Saito K., Layer R., Hartley J.W., Morse H.C. III, Skolnick P., Heyes M.P. Quinolinic acid levels in a murine retrovirus-induced immunodeficiency syndrome. J. Neurochem. 66:1996;296-302.
41. Sei Y., Whitesell L., Kustova Y., Paul I.A., Morse H.C. III, Skolnick P., Basile A.S. Altered brain FYN kinase in a murine acquired immunodeficiency syndrome. FASEB J. 10:1996;339-344.
42. Sharma H.S., Olsson Y., Dey P.K. Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res. 517:1990;215-223.
43. Singer E.J., Syndulko K., Fahy-Chandon B., Schmid P., Conrad A., Tourtelotte W.W. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J. AIDS. 7:1994;265-271.
44. Sparrow J.R. Immunocytochemical study of the blood-brain barrier. Production of an artifact. J. Histochem. Cytochem. 28:1980;570-572.
45. Spencer D.C., Price R.W. Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46:1992;655-693.
46. Tanaka M., Sato A., Okada Y., Makino M., Tabira T. Evidence that brain capillary endothelial cells can be infected with murine leukemia retrovirus, LP-BM5. Neurodegeneration. 5:1996;287-291.
47. Tanno H., Nockels R.P., Pitts L.H., Noble L.G. Breakdown of the blood-brain barrier after fluid percussive brain injury in the rat: Part 1. Distribution and time course of protein extravasation. J. Neurotrauma. 9:1992;21-32.
48. Tao L., Nicholson C. Diffusion of albumins in rat cortical slices and relevance to volume transmission. Neuroscience. 75:1996;839-847.
49. Ueno M., Akiguchi I., Hosokawa M., Yagi H., Takemura M., Kimura J., Takeda T. Accumulation of blood-borne horseradish peroxidase in medial portions of the mouse hippocampus. Acta Neurol. Scand. 90:1994;400-404.
50. Vedeler C., Ulvestad E., Grundt I., Conti G., Nyland H., Matre R., Pleasure D. Fc receptor for IgG (FCR) on rat microglia. J. Neuroimmunol. 49:1994;19-24.
51. Warnick R.E., Fike J.R., Chan P.H., Anderson D.K., Ross G.Y., Gutin P.H. measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J. Neurosci. Meth. 58:1995;167-171.
52. B.V. Zlokovic, J.G. McComb, M.B. Segal, H. Davson, Blood-brain barrier permeability to peptides and proteins, in: M.B. Segal (Ed.), Barriers of the Eye and Brain, CRC Press, Boca Raton, 1992, pp. 205-220.